Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentaglobin in critically ill patients with COVID-19
IRCT20151227025726N18Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2020
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of Pentaglobin in coronavirus pneumonia, sponsored by Shahid Beheshti University of Medical Sciences. Started Jun 2020; status: completed.
02
Drugs
Pentaglobin
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20151227025726N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151227025726N18.